Cite
Anticoagulation Use and Clinical Outcomes After Major Bleeding on Dabigatran or Warfarin in Atrial Fibrillation.
MLA
Hernandez, Inmaculada, et al. “Anticoagulation Use and Clinical Outcomes After Major Bleeding on Dabigatran or Warfarin in Atrial Fibrillation.” Stroke (00392499), vol. 48, no. 1, Jan. 2017, pp. 159–66. EBSCOhost, https://doi.org/10.1161/STROKEAHA.116.015150.
APA
Hernandez, I., Yuting Zhang, Brooks, M. M., Chin, P. K. L., & Saba, S. (2017). Anticoagulation Use and Clinical Outcomes After Major Bleeding on Dabigatran or Warfarin in Atrial Fibrillation. Stroke (00392499), 48(1), 159–166. https://doi.org/10.1161/STROKEAHA.116.015150
Chicago
Hernandez, Inmaculada, Yuting Zhang, Maria M. Brooks, Paul K. L. Chin, and Samir Saba. 2017. “Anticoagulation Use and Clinical Outcomes After Major Bleeding on Dabigatran or Warfarin in Atrial Fibrillation.” Stroke (00392499) 48 (1): 159–66. doi:10.1161/STROKEAHA.116.015150.